Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-13 Sale | 2021-03-15 09:17 am | Viela Bio Inc. | VIE | Chan Mitchell Chief Financial Officer | 37,500 | $53 | $1,987,500 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-17 Option Award | 2025-06-18 4:39 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2025-03-28 Exercise | 2025-04-01 8:06 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,167 | $0 | 9,500 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:59 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 62,547 | $0 | 62,547 (Direct) | View |
| 2024-09-16 Option Award | 2024-09-18 5:04 pm | N/A 2034-09-16 | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 348,231 | $0 | 348,231 (Direct) | View |
| 2024-08-13 Option Award | 2024-08-14 4:56 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 34,100 | $0 | 34,100 (Direct) | View |
| 2023-12-20 Option Award | 2023-12-21 4:01 pm | 2024-12-20 2033-12-20 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,334 | $0 | 3,334 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:23 pm | 2023-06-14 2032-06-14 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-12-01 Option Award | 2021-12-03 8:44 pm | N/A 2031-12-01 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 80,000 | $0 | 80,000 (Direct) | View |